A recent study involving 126 patients with acute spinal cord injuries evaluated the effectiveness of the Anti-Nogo-A antibody. Conducted across various clinics in Germany, Switzerland, the Czech Republic, and Spain, the study found positive effects primarily in patients with incomplete injuries. Researchers, including Karim Fouad from the University of Alberta, express skepticism about a near-future cure for tetraplegia but emphasize the need for continued research into effective treatments.